Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering Claritin ads referring to Seldane proposed withdrawal must mention Allegra -- court order.

Executive Summary

SCHERING CLARITIN ADS MUST INCLUDE MENTION OF ALLEGRA if they are to refer to FDA's proposed withdrawal of Hoechst Marion Roussel's Seldane (terfenadine), Kansas City federal court judge Nanette Laughrey stated in a Feb. 10 temporary restraining order. Laughrey issued the TRO in response to a complaint filed by HMR Feb. 7.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS029742

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel